|
Q1 FY2027
As of Aug 31, 2026
|
Q4 FY2026
As of May 31, 2026
|
Q3 FY2026
As of Feb 28, 2026
|
Q2 FY2026
As of Nov 30, 2025
|
|
|---|---|---|---|---|
| Current Assets | ||||
| Cash and cash equivalents | ||||
| Prepaid expenses | ||||
| Project in progress | ||||
| Total Current Assets | ||||
| Intangible assets, net | ||||
| Total Other Assets | ||||
| TOTAL ASSETS | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Promissory note payable | ||||
| Related party loan payable | ||||
| Total Current Liabilities | ||||
| Related party loan payable | ||||
| Total Long-Term Liabilities | ||||
| Related party loan payable | ||||
| Total Long-Term Liabilities | ||||
| Total Liabilities | ||||
| Stockholders’ Equity (Deficit) | ||||
| Common stock, $0.001 par value; 75,000,000 shares authorized; 5,797,500 shares issued and outstanding as of August 31, 2026 and May 31, 2026 | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Stockholders’ Equity (Deficit) | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
Loading...
